|
MRPL10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.175200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28699999996296E-07 |
| Normal-vs-Stage2 |
8.130800E-01 |
| Normal-vs-Stage3 |
3.726000E-01 |
| Normal-vs-Stage4 |
8.582400E-01 |
| Stage1-vs-Stage2 |
7.463200E-03 |
| Stage1-vs-Stage3 |
2.282000E-03 |
| Stage1-vs-Stage4 |
1.944500E-03 |
| Stage2-vs-Stage3 |
6.886400E-01 |
| Stage2-vs-Stage4 |
9.615000E-01 |
| Stage3-vs-Stage4 |
6.277400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.077600E-03 |
| Normal-vs-AfricanAmerican |
3.416900E-03 |
| Normal-vs-Asian |
8.586300E-02 |
| Caucasian-vs-AfricanAmerican |
2.242000E-01 |
| Caucasian-vs-Asian |
6.318200E-02 |
| AfricanAmerican-vs-Asian |
1.456800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.540700E-03 |
| Normal-vs-Female |
7.176700E-04 |
| Male-vs-Female |
3.050000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.276600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.978400E-03 |
| Normal-vs-Age(61-80Yrs) |
4.900700E-03 |
| Normal-vs-Age(81-100Yrs) |
7.271000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.401600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.912200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.446600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.747400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.207800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.460800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.162100E-03 |
| Normal-vs-Grade 2 |
1.8483699999905E-05 |
| Normal-vs-Grade 3 |
6.689600E-02 |
| Normal-vs-Grade 4 |
9.619200E-01 |
| Grade 1-vs-Grade 2 |
3.549400E-01 |
| Grade 1-vs-Grade 3 |
5.100400E-02 |
| Grade 1-vs-Grade 4 |
4.569800E-02 |
| Grade 2-vs-Grade 3 |
1.496060E-02 |
| Grade 2-vs-Grade 4 |
5.883600E-03 |
| Grade 3-vs-Grade 4 |
2.741800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.84260004213399E-09 |
| Normal-vs-ccB subtype |
6.790600E-01 |
| ccA subtype-vs-ccB subtype |
4.43760000000681E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.639200E-03 |
| Normal-vs-N1 |
1.789170E-01 |
| N0-vs-N1 |
4.745600E-01 |
|
|
